Vanguard Group’s NEPHROGENEX INC COM NRX Stock Holding History

Vanguard Group’s Portfolio NRX Stock Details NRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-73,514	Closed	-$35K	–	4180
2016 Q1	$35K	Sell	73,514 -27,912	-28%	-$23.2K	﹤0.01%	4102
2015 Q4	$162K	Hold	101,426	–	–	﹤0.01%	4035
2015 Q3	$342K	Buy	101,426 +12,900	+15%	+$56.6K	﹤0.01%	3942
2015 Q2	$588K	Buy	88,526 +2,000	+2%	+$15.2K	﹤0.01%	3818
2015 Q1	$681K	Buy	+86,526	New	+$679K	﹤0.01%	3742

Vanguard Group's NRX Position: Q2 2016 in Review

Vanguard Group sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 73,514 shares — an estimated $35K sold.

Vanguard Group first reported a position in NRX in Q1 2015 and held it in 5 quarters. The position peaked at $681K in Q1 2015. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

Vanguard Group reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
Vanguard Group sold 73,514 NEPHROGENEX INC COM shares in Q2 2016, an estimated $35K.
Vanguard Group first reported a position in NEPHROGENEX INC COM in Q1 2015 and held it in 5 quarters.
Vanguard Group's NEPHROGENEX INC COM position peaked at $681K in Q1 2015.
1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on Vanguard Group's 13F filing for Q2 2016, filed 10 Aug 2016.